# Silexion (SLXN) — News

SLXN · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/slxn/news

## Recent headlines

- [Silexion Therapeutics Corp - Serum lipid depletion significantly reduces Sil204 gene-knockdown efficiency](https://www.ainvest.com/news/silexion-therapeutics-corp-serum-lipid-depletion-significantly-reduces-sil204-gene-knockdown-efficiency-2609) — AInvest Wire, Sep 28, 2026
- [Silexion Therapeutics Corp - Sil204 achieves robust gene silencing in KRAS cancer cells with physiological serum lipids](https://www.ainvest.com/news/silexion-therapeutics-corp-sil204-achieves-robust-gene-silencing-kras-cancer-cells-physiological-serum-lipids-2609) — AInvest Wire, Sep 28, 2026
- [Silexion Therapeutics reports positive preclinical findings for Sil204, demonstrating key mechanism for endogenous systemic uptake in KRAS-driven cancers](https://www.ainvest.com/news/silexion-therapeutics-reports-positive-preclinical-findings-sil204-demonstrating-key-mechanism-endogenous-systemic-uptake-kras-driven-cancers-2609) — AInvest Wire, Sep 28, 2026
- [Silexion Therapeutics announces pricing of $2.5 million public offering](https://www.ainvest.com/news/silexion-therapeutics-announces-pricing-2-5-million-public-offering-2608) — AInvest Wire, Aug 12, 2026
- [Silexion Therapeutics Corp: Maxim Group adjusts target price to $6 from $60 to reflect 1-for-10 reverse stock split](https://www.ainvest.com/news/silexion-therapeutics-corp-maxim-group-adjusts-target-price-6-60-reflect-1-10-reverse-stock-split-2606) — AInvest Wire, Jun 24, 2026
  Silexion Therapeutics Corp (SLXN) has announced a 1-for-10 reverse stock split, effective May 29, 2026, reducing the number of outstanding shares and increasing the par value of its ordinary shares from $0.0135 to $0.135 per share. In conjunction with the reverse split, the company’s CUSIP number…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).